BioMed X Launches Ukraine Funding Programme
BioMed X (Heidelberg, Germany) has announced the start of its “Ukraine Refugee Funding Programme” that supports doctoral students and masters-level researchers in the life sciences who cannot continue their work at institutions in Ukraine. In collaboration with some of its partners, BioMed X aims to give these scientists the opportunity to continue their work in a research group at the BioMed X Institute in Heidelberg for a period of up to four years. Candidates should have a master’s degree, as well as research experience, in either molecular/cell biology, bio-organic chemistry, pharmacology, or physics. Knowledge of the German language is not required.
Thomas Rückle, Senior VP and Head of Research at the BioMed X Institute, commented: “The situation in Ukraine is a tragedy that requires a joint effort to offer support and help. Our BioMed X Institute is a place where early-career scientists are given the opportunity to develop themselves. Together with some of our partners we launched this funding programme because we sincerely hope to provide a scientific home for some of the researchers who cannot continue their career in Ukraine.”
For further information, please click here: https://bio.mx/landingpage/ukraine
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
